Sign In
Buy OSUR
$3.95
-0.0500 (-1.25%)
At Close: Jun 03, 2026
OraSure Technologies (OSUR) Reports Next Week: Wall Street Expects Earnings Growth
01:40pm, Monday, 22'nd Feb 2021
OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET
06:00am, Thursday, 18'th Feb 2021
BETHLEHEM, Pa., Feb. 18, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 fourth quarter financial results and certa
OraSure Technologies (OSUR) to Report Q4 Results: Wall Street Expects Earnings Growth
01:12pm, Wednesday, 10'th Feb 2021
OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OraSure Subsidiary DNA Genotek's OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test
06:00am, Friday, 29'th Jan 2021
This is the Eighth EUA to Include a Self-Collection Device from DNA Genotek This is the Eighth EUA to Include a Self-Collection Device from DNA Genotek
OTTAWA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical s
BETHLEHEM, Pa., Jan. 26, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and anal
OraSure's Oragene®•Dx Saliva Collection Kit Included in Industry's First FDA Authorization for a Whole Exome Sequencing Platform
06:00am, Thursday, 21'st Jan 2021
BETHLEHEM, Pa., Jan. 21, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and anal
OraSure: Well Positioned Ex-Covid, Sell Side Missing The Organic Growth Drivers
12:58pm, Tuesday, 12'th Jan 2021
OraSure: Well Positioned Ex-Covid, Sell Side Missing The Organic Growth Drivers
OraSure Technologies Announces 2021 Annual Meeting Date
06:00am, Friday, 08'th Jan 2021
BETHLEHEM, Pa., Jan. 08, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2021 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
06:00am, Tuesday, 05'th Jan 2021
BETHLEHEM, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and a
OraSure's OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test
06:00am, Wednesday, 23'rd Dec 2020
OTTAWA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical s
BETHLEHEM, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today disclosed that the U.S. F
OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference
07:00am, Monday, 30'th Nov 2020
BETHLEHEM, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephe
Stock Upgrades: Orasure Technologies Shows Rising Relative Strength
03:52pm, Monday, 09'th Nov 2020
A Relative Strength Rating upgrade for Orasure Technologies shows improving technical performance. The post Stock Upgrades: Orasure Technologies Shows Rising Relative Strength appeared first on Invest
OraSure Technologies, Inc. (OSUR) CEO Stephen Tang on Q3 2020 Results - Earnings Call Transcript
08:58pm, Wednesday, 04'th Nov 2020
OraSure Technologies, Inc. (OSUR) CEO Stephen Tang on Q3 2020 Results - Earnings Call Transcript
